Europe counts the high cost of deafness:
This article was originally published in Clinica
Executive Summary
Some E78m ($92m) is spent in Europe each year on patients with hearing impairment, European Commission figures suggest. This is higher than the combined costs of epilepsy, multiple sclerosis, spinal injury, strokes and Parkinson's disease, according to Cordis Focus, the Commission's newsletter. Over 22 million people in Europe have some kind of hearing impairment and of these some 3 million cannot hear any sound below 80-100 decibels. Some 50% of all hearing impairments have a genetic origin. There are 36 genes known to be associated with deafness. It appears that Connexin 26 is responsible for more than 30% of all deafness cases in Europe.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.